Inhibitory regulation of rat exocrine pancreas by peptide YY and pancreatic polypeptide

Am J Physiol. 1989 Apr;256(4 Pt 1):G698-703. doi: 10.1152/ajpgi.1989.256.4.G698.

Abstract

Peptide YY (PYY) and pancreatic polypeptide (PP) have been shown to inhibit exocrine pancreatic secretion in vivo in a variety of species. This study evaluates the type of stimulation inhibited by PYY and PP by examining, in urethan-anesthetized rats, the inhibition of pancreatic secretion when stimulated to a comparable extent by cholecystokinin (CCK), 2-deoxy-D-glucose (2DG), bethanecol, and electrical vagal nerve stimulation. PYY at maximal infusion rates inhibited stimulation by CCK by 83%, bethanecol by 55%, and electrical nerve stimulation by 40%. The inhibition of CCK stimulation was half maximal at 250 pmol.kg-1.h-1. By contrast, PYY totally inhibited 2DG-stimulated secretion with half-maximal inhibition at 10 pmol. kg-1.h-1. PP acted similarly to PYY in inhibiting CCK and 2DG-stimulated pancreatic protein secretion but was fivefold weaker in each case. These findings indicate that PYY and PP have multiple actions but preferentially inhibit neurally mediated pancreatic secretion at a preacinar cell locus, possibly at a central site of action.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bethanechol
  • Bethanechol Compounds / pharmacology
  • Cholecystokinin / pharmacology
  • Deoxyglucose / pharmacology
  • Electric Stimulation
  • Male
  • Pancreas / drug effects
  • Pancreas / innervation
  • Pancreas / metabolism*
  • Pancreatic Polypeptide / pharmacology*
  • Peptide YY
  • Peptides / pharmacology*
  • Proteins / metabolism
  • Rats
  • Rats, Inbred Strains
  • Vagus Nerve / physiology

Substances

  • Bethanechol Compounds
  • Peptides
  • Proteins
  • Bethanechol
  • Peptide YY
  • Pancreatic Polypeptide
  • Cholecystokinin
  • Deoxyglucose